InspireMD Closes Public Offering To Save Company From Immanent Demise
This article was originally published in Clinica
Executive Summary
InspireMD announced the closing of two separate equity offerings, worth a total of $1.75m on March 31, just a few days after disclosing that an independent audit concluded that the Israeli embolic protection device-maker did not have enough money to survive past May.